Characteristics of Mel Ibr Melanoma Line Subclone after Treatment with Chicken Embryo Extract
- Авторы: Suraeva N.M.1, Morozova L.F.1, Ryabaya O.O.1, Khochenkova Y.A.1, Samoilov A.V.2, Burova O.S.1, Golubtsova N.V.1, Barmashov A.E.1, Baryshnikova M.A.1
- 
							Учреждения: 
							- N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
- All-Russian Research Institute of Preservation Technology
 
- Выпуск: Том 163, № 2 (2017)
- Страницы: 255-259
- Раздел: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/238795
- DOI: https://doi.org/10.1007/s10517-017-3778-y
- ID: 238795
Цитировать
Аннотация
We continue analysis of the phenotype of human melanoma cell Mel Ibr subclone obtained previously by treatment of the parental cell line by chicken embryo extract. The present study is focused on detection of markers of epithelial-mesenchymal transition that determine enhanced metastatic and invasive potential of malignant tumors of various locations. Analysis of the expression of E-cadherin and vimentin genes in the subclone and parental cells detected activation of epithelial-mesenchymal transition in the subclone. Immunological markers CD90, CD271, and CD95 were present in the parental population, but were not detected on the subclone cells. In contrast to the parental line, cells of the analyzed subclone retain viability in serum-free medium and formed vessel-like structures characteristic of vasculogenic mimicry.
Об авторах
N. Suraeva
N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
							Автор, ответственный за переписку.
							Email: nsuraeva@yandex.ru
				                					                																			                												                	Россия, 							Moscow						
L. Morozova
N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
														Email: nsuraeva@yandex.ru
				                					                																			                												                	Россия, 							Moscow						
O. Ryabaya
N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
														Email: nsuraeva@yandex.ru
				                					                																			                												                	Россия, 							Moscow						
Yu. Khochenkova
N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
														Email: nsuraeva@yandex.ru
				                					                																			                												                	Россия, 							Moscow						
A. Samoilov
All-Russian Research Institute of Preservation Technology
														Email: nsuraeva@yandex.ru
				                					                																			                												                	Россия, 							Moscow Region						
O. Burova
N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
														Email: nsuraeva@yandex.ru
				                					                																			                												                	Россия, 							Moscow						
N. Golubtsova
N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
														Email: nsuraeva@yandex.ru
				                					                																			                												                	Россия, 							Moscow						
A. Barmashov
N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
														Email: nsuraeva@yandex.ru
				                					                																			                												                	Россия, 							Moscow						
M. Baryshnikova
N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
														Email: nsuraeva@yandex.ru
				                					                																			                												                	Россия, 							Moscow						
Дополнительные файлы
 
				
			 
						 
					 
						 
						 
						 
									 
  
  
  
  
  Отправить статью по E-mail
			Отправить статью по E-mail  Открытый доступ
		                                Открытый доступ Доступ предоставлен
						Доступ предоставлен Только для подписчиков
		                                		                                        Только для подписчиков
		                                					